SlideShare a Scribd company logo
SEMINAR ON –
DERMAL IRRITATION AND DERMAL TOXICITY
Subject: Pharmacological & Toxicological Screening method- II
A.R College of Pharmacy and G. H Patel Institute of Pharmacy
Vallabh Vidyanagar, Anand
Guided By
Ms. M. S. Saiyed
Assistant Professor
M. Pharm
Department of Pharmacology
Presented By
Dinesh M Gangoda
Class: M. Pharm (Sem-II)
Roll No- MPL04
CONTENTS
Dermal irritation
• Introduction
• Principle
• Preparation of the in vivo test
• Test Procedure( Methodology)
• Observation and Grading scores
Dermal Toxicity
• Introduction
• Principle
• Test Procedure
References
2
DERMAL IRRITATION
Introduction
 Dermal irritation is the production of reversible damage of the skin following the
application of a test chemical for up to 4 hours.
 Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end
of observation at 14 days, by discolouration due to blanching of the skin,
complete areas of alopecia, and scars. Histopathology should be considered to
evaluate questionable lesions. [1]
 Dermal corrosion is the production of irreversible damage of the skin; namely,
visible necrosis through the epidermis and into the dermis, following the
application of a test chemical for up to four hours.[2]
3
PRINCIPLE:
 The test chemical to be tested is applied in a single dose to the skin of an
experimental animal; untreated skin areas of the test animal serve as the
control.
 The degree of irritation/corrosion is read and scored at specified intervals and
is further described in order to provide a complete evaluation of the effects.
 The duration of the study should be sufficient to evaluate the reversibility or
irreversibility of the effects observed.
 Animals showing continuing signs of severe distress and/or pain at any stage
of the test should be humanely killed, and the test chemical assessed
accordingly.
 Criteria for making the decision to humanely kill moribund and severely
suffering animals are the subject of a separate guidance document. [1]
4
PREPARATIONS FOR THE IN VIVO TEST
Selection of animal species:
 The Albino Rabbit is the preferable
laboratory animal and healthy young
adult rabbits are used.
 A rationale for using other species
should be provided.
Albino Rabbit
5
 Approximately 24 hours before the test, for
should be removed by closely clipping the dorsal
area of the trunk of the animals.
 Care should be taken to avoid abrading the skin,
and only animals with healthy, intact skin should
be used.
 Some strains of rabbit have dense patches of hair
that are more prominent at certain times of the
year. Such areas of dense hair growth should not
be used as test sites.
Albino Rabbit
Cont..
6
Housing and feeding conditions:
 Rabbit at least 12 weeks old and body weight 1.5 kg-3.0 kg.
 The temperature should be 200C (± 30C) for rabbits.
 Relative humidity should be at least 30% and preferably not exceed 70%, other than
during room cleaning; the aim should be 50-60%.
 Lighting should be 12 hours light, 12 hours dark.
 For feeding, conventional laboratory diets may be used with an unrestricted supply
of drinking water.
7
 Rabbits are especially susceptible to the effects of stress and should always be
approached in a calm and confident manner.
 The handler is restraining the rabbit firmly by the scruff with the other hand
ready to support the animal’s hindquarters.
 There is no one correct method of handling or restraining animals, but the
general principle is that it should not cause pain or discomfort to the animal. It
should also be comfortable for the handler.
HANDLING AND RESTRAINT
8
Figure: Handling and Restraint of Rabbit
9
Dose level
 A dose of 0.5 mL of liquid or 0.5 g of solid or paste is applied to the test site.
Application of the test chemical:
 The test chemical should be applied to a dorsal/flank region (approximately 6 cm
2) of skin and covered with a gauze patch, which is held in place with non-
irritating tape.
 In cases in which direct application is not possible (e.g., liquids or some pastes),
the test chemical should first be applied to the gauze patch, which is then applied
to the skin.
 The patch should be loosely held in contact with the skin by means of a suitable
semi-occlusive dressing for the duration of the exposure period.
TEST PROCEDURE[1]
10
Figure: Test chemical applied to a dorsal/flank region in Rabbit 11
CONT..
 If the test chemical is applied to the patch, it should be attached to the skin in
such a manner that there is good contact and uniform distribution of the test
chemical on the skin.
 Access by the animal to the patch and ingestion or inhalation of the test chemical
should be prevented.
 Liquid test chemicals are generally used undiluted.
 When testing solids (which may be pulverised, if considered necessary), the test
chemical should be moistened with the smallest amount of water (or, where
necessary, of another suitable vehicle) sufficient to ensure good skin contact.
12
CONT..
 When vehicles other than water are used, the potential influence of the vehicle on
irritation of the skin by the test chemical should be minimal, if any.
 At the end of the exposure period, which is normally 4 hours, residual test
chemical should be removed, where practicable, using water or an appropriate
solvent without altering the existing response or the integrity of the epidermis.[3]
13
INITIAL TEST (USING ONE ANIMAL)[1]
 When a test chemical has been judged to be corrosive, irritant or non-classified on the
basis of a weight of evidence analyses or of previous in vitro testing, further in vivo
testing is normally not necessary.
 However, in the cases where additional data are felt warranted, the in vivo test is
performed initially using one animal and applying the following approach.
 Up to three test patches are applied sequentially to the animal. The first patch is
removed after three minutes.
14
 If no serious skin reaction is observed, a second patch is applied at a different
site and removed after one hour.
 If the observations at this stage indicate that exposure can humanely be
allowed to extend to four hours, a third patch is applied and removed after
four hours, and the response is graded.
15
CONT..
 If a corrosive effect is observed after any of the three sequential exposures, the test is
immediately terminated.
 If a corrosive effect is not observed after the last patch is removed, the animal is
observed for 14 days, unless corrosion develops at an earlier time point.
 In those case in which the test chemical is not expected to produce corrosion but may
be irritating, a single patch should be applied to one animal for four hours.
16
CONFIRMATORY TEST (WITH ADDITIONAL ANIMALS)
 If a corrosive effect is not observed in the initial test, the irritant or negative
response should be confirmed using up to two additional animals, each with one
patch, for an exposure period of four hours.
 If an irritant effect is observed in the initial test, the confirmatory test may be
conducted in a sequential manner, or by exposing two additional animals
simultaneously.
17
 In the exceptional case, in which the initial test is not conducted, two or three
animals may be treated with a single patch, which is removed after four hours.
 When two animals are used, if both exhibit the same response, no further testing
is needed. Otherwise, the third animal is also tested.
 Equivocal responses may need to be evaluated using additional animals.
18
OBSERVATION PERIOD
 The duration of the observation period should be sufficient to evaluate fully the
reversibility of the effects observed.
 The experiment should be terminated at any time that the animal shows
continuing signs of severe pain or distress.
 To determine the reversibility of effects, the animals should be observed up to 14
days after removal of the patches.
 If reversibility is seen before 14 days, the experiment should be terminated at that
time.
19
CLINICAL OBSERVATIONS AND GRADING OF SKIN REACTIONS:
 All animals should be examined for signs of erythema and oedema, and the
responses scored at 60 minutes, and then at 24, 48 and 72 hours after patch
removal.
 For the initial test in one animal, the test site is also examined immediately after
the patch has been removed.
 If there is damage to skin which cannot be identified as irritation or corrosion at 72
hours, observations may be needed until day 14 to determine the reversibility of the
effects.
 In addition to the observation of irritation, all local toxic effects, such as defatting
of the skin, and any systemic adverse effects (e.g., effects on clinical signs of
toxicity and body weight), should be fully described and recorded.
20
Erythema and Eschar Formation Grades
No erythema 0
Very slight erythema (barely perceptible) 1
Well defined erythema 2
Moderate to severe erythema 3
Severe erythema (beef redness) to eschar
formation preventing grading of erythema
4
Maximum possible: 4
TABLE: GRADING OF SKIN REACTIONS [1]
Erythema and Eschar Formation
21
GRADING OF SKIN REACTIONS [1]
22
Oedema Formation Grades
No oedema 0
Very slight oedema (barely perceptible) 1
Slight oedema (edges of area well defined by
definite raising)
2
Moderate oedema (raised approximately 1 mm) 3
Severe oedema (raised more than 1mm and
extending beyond area of exposure)
4
Maximum possible: 4
Oedema Formation [1]
23
DERMAL TOXICITY STUDIES
Introduction
 Dermal toxicity involves the assessment and evaluation of the toxic
characteristics of a substance. It is useful where the exposure to dermal route is
likely. [3]
24
Principle:
• The test substance is applied to the skin in graduated doses to several groups of
experimental animals.
• Animals which die during the test are necropsied and surviving animals are also
done the same at the conclusion.
• Animals showing severe and enduring sings of distress and pain may need to be
humanely killed.
25
Requirements:
Selection of species: Albino Rabbit
Body weight:
• Rabbit- 1.5 to 3.0 gm
Age:
• Rabbit- at least 12 weeks old
Sex:
• Male/ female
Dose: 200mg/kg
Figure: Albino Rabbit 26
Preparation of test item;
 Solid- Moistened with distilled water/vehicle
 Liquids- applied directly without dilution.
Preparation of test animals:
 One day before application of the items, 10% of the total body surface area of the
animals will be clipped with electric clipper/ shaved with razor blade/ depilated
with VEET cream.
 The position of clipping will be the area starting at the scapulae(shoulders) to
wring of the ilium (hipbone) and half way down the flunk on each side.
27
 Test material should be applied on shaved skin covering not less than 10% of the
total body surface area.
 Porous gauze dressing should be used to hold liquid material in place.
 Formulations with different concentrations (at least 3) of test substance, several
fold higher than the clinical dosage form should be used.
Test Procedure
28
 Period of application may vary from 7 to 90 days depending on the clinical duration
of use.
 Where skin irritation is grossly visible in the initial studies, a recovery group should
be included in the subsequent repeated study.
 Local signs (erythema, oedema and Escher formation) as well as histopathological
examination of sites of application should be used for evaluation of results.
29
CONT..
After the test animals look like:
30
REFERENCES
1. OECD/OCDE, Test No. 404: ‘‘Acute Dermal Irritation/Corrosion’’, 28
July 2015 OECD Publishing, peris, Page no, 1- 8.
2. Robert A., Turner., Screening Methods in Pharmacology; 1st edition;
Academic press an imprint of Elsevier, pp, 279- 281.
3. OECD Guideline for testing of chemicals (1981). ‘‘Repeated Dose
Dermal Toxicity’’, 21/28- day study. Page no-1.
31
32

More Related Content

What's hot

Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
helasri gummadi
 
Inhalation Toxicity Studies- OECD guidelines
 Inhalation Toxicity Studies- OECD guidelines Inhalation Toxicity Studies- OECD guidelines
Inhalation Toxicity Studies- OECD guidelines
Cerin Philip
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
Kashikant Yadav
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
Khadga Raj
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
ARSHIKHANAM4
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)
Ramavath Aruna
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testing
Sachin Sharma
 
Acute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelinesAcute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelines
madhvi Chaubey
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
SONALPANDE5
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
Grandhi sandeep ganesh
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
pradnya Jagtap
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
ragini Dani
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
Sanchit Dhankhar
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
HimikaRathi
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Shivam Diwaker
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
Ramavath Aruna
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
JanhaviBurade
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
ashharnomani
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
Anmolkanda06
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
pharmacistnitish
 

What's hot (20)

Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
Oecd acute,subacte, sub chronic dermal toxicity studies(402, 410, 411).
 
Inhalation Toxicity Studies- OECD guidelines
 Inhalation Toxicity Studies- OECD guidelines Inhalation Toxicity Studies- OECD guidelines
Inhalation Toxicity Studies- OECD guidelines
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
Safety pharmacology (siri)
Safety pharmacology (siri)Safety pharmacology (siri)
Safety pharmacology (siri)
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testing
 
Acute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelinesAcute eye irritation test as per OECD guidelines
Acute eye irritation test as per OECD guidelines
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Screening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentizationScreening models for acute eye irritation & skin sentization
Screening models for acute eye irritation & skin sentization
 
Safety pharmacology tier 2
Safety pharmacology  tier 2Safety pharmacology  tier 2
Safety pharmacology tier 2
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
Toxicokinetic evaluation in preclinical studies by Shivam Diwaker
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 

Similar to Dermal Irritation and Dermal Toxicity Studies

Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptxDermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Ashish Gadage
 
dermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptxdermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptx
yashvikhankar1
 
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINESDERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
MO.SHAHANAWAZ
 
acute dermal irritation .pptx
acute dermal irritation .pptxacute dermal irritation .pptx
acute dermal irritation .pptx
jatinsaini78
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404
Dr Ajay Mandal
 
dermal toxicity.pptx
dermal toxicity.pptxdermal toxicity.pptx
dermal toxicity.pptx
VaishnaviPatel76
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Ch. Bhargava krishna
 
skin sensitisation test
 skin sensitisation test skin sensitisation test
skin sensitisation test
mominasran
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
Himanshu Yadav
 
Skin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptxSkin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptx
NikitaBankoti2
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
Priya818982
 
Patch Test
Patch TestPatch Test
Patch Test
NishkarshChugh1
 
Patch Test in Dermatology
Patch Test in Dermatology Patch Test in Dermatology
Patch Test in Dermatology
NishkarshChugh
 
BioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptxBioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptx
HafezHawas1
 
Acute Eye Irritation\Corrosion toxicology studies
Acute Eye Irritation\Corrosion  toxicology studiesAcute Eye Irritation\Corrosion  toxicology studies
Acute Eye Irritation\Corrosion toxicology studies
Himanshu Yadav
 
Expt. 10 Determination of acute skin irritation corrosion of a test substance
Expt. 10 Determination of acute skin irritation  corrosion of a test substanceExpt. 10 Determination of acute skin irritation  corrosion of a test substance
Expt. 10 Determination of acute skin irritation corrosion of a test substance
VISHALJADHAV100
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
Dr Ajay Mandal
 
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptxAcute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Dublinmatcher
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Patel Parth
 
Expt. 11 Determination of acute eye irritation corrosion of a test substance
Expt. 11 Determination of acute eye irritation  corrosion of a test substanceExpt. 11 Determination of acute eye irritation  corrosion of a test substance
Expt. 11 Determination of acute eye irritation corrosion of a test substance
VISHALJADHAV100
 

Similar to Dermal Irritation and Dermal Toxicity Studies (20)

Dermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptxDermal Irritation & corrosion PTSM ASHISH AG.pptx
Dermal Irritation & corrosion PTSM ASHISH AG.pptx
 
dermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptxdermal irritation and dermal toxicity studies.pptx
dermal irritation and dermal toxicity studies.pptx
 
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINESDERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
DERMAL IRRITATION STUDY ACCORDING TO OECD(404) GUIDELINES
 
acute dermal irritation .pptx
acute dermal irritation .pptxacute dermal irritation .pptx
acute dermal irritation .pptx
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404
 
dermal toxicity.pptx
dermal toxicity.pptxdermal toxicity.pptx
dermal toxicity.pptx
 
Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...Screening methods for skin sensitization, skin irritation and dermal toxicity...
Screening methods for skin sensitization, skin irritation and dermal toxicity...
 
skin sensitisation test
 skin sensitisation test skin sensitisation test
skin sensitisation test
 
Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)Skin sensitization test (oecd 406)
Skin sensitization test (oecd 406)
 
Skin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptxSkin sensitisation, OECD Test guideline 406 .pptx
Skin sensitisation, OECD Test guideline 406 .pptx
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
 
Patch Test
Patch TestPatch Test
Patch Test
 
Patch Test in Dermatology
Patch Test in Dermatology Patch Test in Dermatology
Patch Test in Dermatology
 
BioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptxBioSafety merged projects e budget.pptx
BioSafety merged projects e budget.pptx
 
Acute Eye Irritation\Corrosion toxicology studies
Acute Eye Irritation\Corrosion  toxicology studiesAcute Eye Irritation\Corrosion  toxicology studies
Acute Eye Irritation\Corrosion toxicology studies
 
Expt. 10 Determination of acute skin irritation corrosion of a test substance
Expt. 10 Determination of acute skin irritation  corrosion of a test substanceExpt. 10 Determination of acute skin irritation  corrosion of a test substance
Expt. 10 Determination of acute skin irritation corrosion of a test substance
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
 
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptxAcute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
Acute,Sub-acute and Sub-chronic dermal toxicity studies.pptx
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018
 
Expt. 11 Determination of acute eye irritation corrosion of a test substance
Expt. 11 Determination of acute eye irritation  corrosion of a test substanceExpt. 11 Determination of acute eye irritation  corrosion of a test substance
Expt. 11 Determination of acute eye irritation corrosion of a test substance
 

Recently uploaded

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
The Lifesciences Magazine
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
ranishasharma67
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
Pooja Rani
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Rommel Luis III Israel
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
PGIMS Rohtak
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
Esam43
 

Recently uploaded (20)

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
💘Ludhiana ℂall Girls 📞]][89011★83002][[ 📱 ❤ESCORTS service in Ludhiana💃💦Ludhi...
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
ventilator, child on ventilator, newborn
ventilator, child on ventilator, newbornventilator, child on ventilator, newborn
ventilator, child on ventilator, newborn
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.pptNursing Care of Client With Acute And Chronic Renal Failure.ppt
Nursing Care of Client With Acute And Chronic Renal Failure.ppt
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
CONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docxCONSTRUCTION OF TEST IN MANAGEMENT .docx
CONSTRUCTION OF TEST IN MANAGEMENT .docx
 
Yemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .pptYemen National Tuberculosis Program .ppt
Yemen National Tuberculosis Program .ppt
 

Dermal Irritation and Dermal Toxicity Studies

  • 1. SEMINAR ON – DERMAL IRRITATION AND DERMAL TOXICITY Subject: Pharmacological & Toxicological Screening method- II A.R College of Pharmacy and G. H Patel Institute of Pharmacy Vallabh Vidyanagar, Anand Guided By Ms. M. S. Saiyed Assistant Professor M. Pharm Department of Pharmacology Presented By Dinesh M Gangoda Class: M. Pharm (Sem-II) Roll No- MPL04
  • 2. CONTENTS Dermal irritation • Introduction • Principle • Preparation of the in vivo test • Test Procedure( Methodology) • Observation and Grading scores Dermal Toxicity • Introduction • Principle • Test Procedure References 2
  • 3. DERMAL IRRITATION Introduction  Dermal irritation is the production of reversible damage of the skin following the application of a test chemical for up to 4 hours.  Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology should be considered to evaluate questionable lesions. [1]  Dermal corrosion is the production of irreversible damage of the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test chemical for up to four hours.[2] 3
  • 4. PRINCIPLE:  The test chemical to be tested is applied in a single dose to the skin of an experimental animal; untreated skin areas of the test animal serve as the control.  The degree of irritation/corrosion is read and scored at specified intervals and is further described in order to provide a complete evaluation of the effects.  The duration of the study should be sufficient to evaluate the reversibility or irreversibility of the effects observed.  Animals showing continuing signs of severe distress and/or pain at any stage of the test should be humanely killed, and the test chemical assessed accordingly.  Criteria for making the decision to humanely kill moribund and severely suffering animals are the subject of a separate guidance document. [1] 4
  • 5. PREPARATIONS FOR THE IN VIVO TEST Selection of animal species:  The Albino Rabbit is the preferable laboratory animal and healthy young adult rabbits are used.  A rationale for using other species should be provided. Albino Rabbit 5
  • 6.  Approximately 24 hours before the test, for should be removed by closely clipping the dorsal area of the trunk of the animals.  Care should be taken to avoid abrading the skin, and only animals with healthy, intact skin should be used.  Some strains of rabbit have dense patches of hair that are more prominent at certain times of the year. Such areas of dense hair growth should not be used as test sites. Albino Rabbit Cont.. 6
  • 7. Housing and feeding conditions:  Rabbit at least 12 weeks old and body weight 1.5 kg-3.0 kg.  The temperature should be 200C (± 30C) for rabbits.  Relative humidity should be at least 30% and preferably not exceed 70%, other than during room cleaning; the aim should be 50-60%.  Lighting should be 12 hours light, 12 hours dark.  For feeding, conventional laboratory diets may be used with an unrestricted supply of drinking water. 7
  • 8.  Rabbits are especially susceptible to the effects of stress and should always be approached in a calm and confident manner.  The handler is restraining the rabbit firmly by the scruff with the other hand ready to support the animal’s hindquarters.  There is no one correct method of handling or restraining animals, but the general principle is that it should not cause pain or discomfort to the animal. It should also be comfortable for the handler. HANDLING AND RESTRAINT 8
  • 9. Figure: Handling and Restraint of Rabbit 9
  • 10. Dose level  A dose of 0.5 mL of liquid or 0.5 g of solid or paste is applied to the test site. Application of the test chemical:  The test chemical should be applied to a dorsal/flank region (approximately 6 cm 2) of skin and covered with a gauze patch, which is held in place with non- irritating tape.  In cases in which direct application is not possible (e.g., liquids or some pastes), the test chemical should first be applied to the gauze patch, which is then applied to the skin.  The patch should be loosely held in contact with the skin by means of a suitable semi-occlusive dressing for the duration of the exposure period. TEST PROCEDURE[1] 10
  • 11. Figure: Test chemical applied to a dorsal/flank region in Rabbit 11
  • 12. CONT..  If the test chemical is applied to the patch, it should be attached to the skin in such a manner that there is good contact and uniform distribution of the test chemical on the skin.  Access by the animal to the patch and ingestion or inhalation of the test chemical should be prevented.  Liquid test chemicals are generally used undiluted.  When testing solids (which may be pulverised, if considered necessary), the test chemical should be moistened with the smallest amount of water (or, where necessary, of another suitable vehicle) sufficient to ensure good skin contact. 12
  • 13. CONT..  When vehicles other than water are used, the potential influence of the vehicle on irritation of the skin by the test chemical should be minimal, if any.  At the end of the exposure period, which is normally 4 hours, residual test chemical should be removed, where practicable, using water or an appropriate solvent without altering the existing response or the integrity of the epidermis.[3] 13
  • 14. INITIAL TEST (USING ONE ANIMAL)[1]  When a test chemical has been judged to be corrosive, irritant or non-classified on the basis of a weight of evidence analyses or of previous in vitro testing, further in vivo testing is normally not necessary.  However, in the cases where additional data are felt warranted, the in vivo test is performed initially using one animal and applying the following approach.  Up to three test patches are applied sequentially to the animal. The first patch is removed after three minutes. 14
  • 15.  If no serious skin reaction is observed, a second patch is applied at a different site and removed after one hour.  If the observations at this stage indicate that exposure can humanely be allowed to extend to four hours, a third patch is applied and removed after four hours, and the response is graded. 15
  • 16. CONT..  If a corrosive effect is observed after any of the three sequential exposures, the test is immediately terminated.  If a corrosive effect is not observed after the last patch is removed, the animal is observed for 14 days, unless corrosion develops at an earlier time point.  In those case in which the test chemical is not expected to produce corrosion but may be irritating, a single patch should be applied to one animal for four hours. 16
  • 17. CONFIRMATORY TEST (WITH ADDITIONAL ANIMALS)  If a corrosive effect is not observed in the initial test, the irritant or negative response should be confirmed using up to two additional animals, each with one patch, for an exposure period of four hours.  If an irritant effect is observed in the initial test, the confirmatory test may be conducted in a sequential manner, or by exposing two additional animals simultaneously. 17
  • 18.  In the exceptional case, in which the initial test is not conducted, two or three animals may be treated with a single patch, which is removed after four hours.  When two animals are used, if both exhibit the same response, no further testing is needed. Otherwise, the third animal is also tested.  Equivocal responses may need to be evaluated using additional animals. 18
  • 19. OBSERVATION PERIOD  The duration of the observation period should be sufficient to evaluate fully the reversibility of the effects observed.  The experiment should be terminated at any time that the animal shows continuing signs of severe pain or distress.  To determine the reversibility of effects, the animals should be observed up to 14 days after removal of the patches.  If reversibility is seen before 14 days, the experiment should be terminated at that time. 19
  • 20. CLINICAL OBSERVATIONS AND GRADING OF SKIN REACTIONS:  All animals should be examined for signs of erythema and oedema, and the responses scored at 60 minutes, and then at 24, 48 and 72 hours after patch removal.  For the initial test in one animal, the test site is also examined immediately after the patch has been removed.  If there is damage to skin which cannot be identified as irritation or corrosion at 72 hours, observations may be needed until day 14 to determine the reversibility of the effects.  In addition to the observation of irritation, all local toxic effects, such as defatting of the skin, and any systemic adverse effects (e.g., effects on clinical signs of toxicity and body weight), should be fully described and recorded. 20
  • 21. Erythema and Eschar Formation Grades No erythema 0 Very slight erythema (barely perceptible) 1 Well defined erythema 2 Moderate to severe erythema 3 Severe erythema (beef redness) to eschar formation preventing grading of erythema 4 Maximum possible: 4 TABLE: GRADING OF SKIN REACTIONS [1] Erythema and Eschar Formation 21
  • 22. GRADING OF SKIN REACTIONS [1] 22
  • 23. Oedema Formation Grades No oedema 0 Very slight oedema (barely perceptible) 1 Slight oedema (edges of area well defined by definite raising) 2 Moderate oedema (raised approximately 1 mm) 3 Severe oedema (raised more than 1mm and extending beyond area of exposure) 4 Maximum possible: 4 Oedema Formation [1] 23
  • 24. DERMAL TOXICITY STUDIES Introduction  Dermal toxicity involves the assessment and evaluation of the toxic characteristics of a substance. It is useful where the exposure to dermal route is likely. [3] 24
  • 25. Principle: • The test substance is applied to the skin in graduated doses to several groups of experimental animals. • Animals which die during the test are necropsied and surviving animals are also done the same at the conclusion. • Animals showing severe and enduring sings of distress and pain may need to be humanely killed. 25
  • 26. Requirements: Selection of species: Albino Rabbit Body weight: • Rabbit- 1.5 to 3.0 gm Age: • Rabbit- at least 12 weeks old Sex: • Male/ female Dose: 200mg/kg Figure: Albino Rabbit 26
  • 27. Preparation of test item;  Solid- Moistened with distilled water/vehicle  Liquids- applied directly without dilution. Preparation of test animals:  One day before application of the items, 10% of the total body surface area of the animals will be clipped with electric clipper/ shaved with razor blade/ depilated with VEET cream.  The position of clipping will be the area starting at the scapulae(shoulders) to wring of the ilium (hipbone) and half way down the flunk on each side. 27
  • 28.  Test material should be applied on shaved skin covering not less than 10% of the total body surface area.  Porous gauze dressing should be used to hold liquid material in place.  Formulations with different concentrations (at least 3) of test substance, several fold higher than the clinical dosage form should be used. Test Procedure 28
  • 29.  Period of application may vary from 7 to 90 days depending on the clinical duration of use.  Where skin irritation is grossly visible in the initial studies, a recovery group should be included in the subsequent repeated study.  Local signs (erythema, oedema and Escher formation) as well as histopathological examination of sites of application should be used for evaluation of results. 29
  • 30. CONT.. After the test animals look like: 30
  • 31. REFERENCES 1. OECD/OCDE, Test No. 404: ‘‘Acute Dermal Irritation/Corrosion’’, 28 July 2015 OECD Publishing, peris, Page no, 1- 8. 2. Robert A., Turner., Screening Methods in Pharmacology; 1st edition; Academic press an imprint of Elsevier, pp, 279- 281. 3. OECD Guideline for testing of chemicals (1981). ‘‘Repeated Dose Dermal Toxicity’’, 21/28- day study. Page no-1. 31
  • 32. 32